"Ion channels and transporters as molecular drug targets" (MolTag) is a PhD/doctoral program in pharmaceutical sciences established at the University of Vienna, the Medical University of Vienna, the Vienna University of Technology and the Institute of Science and Technology Austria at Klosterneuburg. The graduate program is financed by a research grant of the Austrian Science Fund (FWF) since 2011. MolTag offers a broad three-year PhD education in pharmaceutical sciences including specialized field courses such as molecular pharmacology, pharmacoinformatics, structure-function analysis of target molecules, biophysics, imaging and advanced synthetic chemistry. Applicants at MolTag have completed a diploma study in medicine or a high quality master program in natural sciences, such as pharmacy, biology, molecular biology or chemistry. MolTag provides comprehensive training in relevant research areas of pharmaceutical research, with focus on drug discovery and drug development. MolTag will provide PhD students with contacts to national and international research labs, including the pharmaceutical industry. We aim to create an atmosphere of collaborative and interdisciplinary research.

The MolTag Movie

TEASER (2 min)

Curious to see what the "MolTag PhD program" is all about? With an introduction by our program speaker, Prof. Gerhard Ecker, and a very personal definition of what MolTag means to them by the students, we would like to give here a short glimpse into the MolTag movie.


The last cohort of MolTag students of the FWF-funded Doctoral Program "Molecular Drug Targets" explain and illustrate their work and research goals on drug targets with their very own interdisciplinary MolTag approach. Under the Corona conditions in 2021, the students have written the script and concept using video chats and shared documents. With professional support for camera and editing, this resulted in an inspiring and enthusiastic film document of the MolTag PhD students of 2021.

The complete film (21 min) illustrates the interdisciplinary research that is pursued in our groups.



Latest News


Michi Jirout, University of Vienna, and Lisa Knaus, IST Austria, defended their thesis succesfully this month!


Her article "Large neutral amino acid levels tune perinatal neuronal excitability and survival" reveived much attention!


Save the date: September 25+26 in Vienna! Registration open!

Latest Announcements


We are happy to welcome Prof. Diomedes Logothethis, Northeastern University, Boston, MA in Vienna as our next guest lecturer!


Mark Cronin is Professor of Predictive Toxicology at the School of Pharmacy and Biomolecular Sciences, Liverpool John Moores Univ.


Marcel Van der Heyden will discuss the development of the CAVB model from its beginning and also will reflect on safety pharmacology studies, efficacy...